These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [From gene to disease; the haemolytic uraemic syndrome can be caused by mutations in regulating factors of the alternative route of the complement system]. Geelen JM; Klasen IS; van den Heuvel LP; Monnens LA Ned Tijdschr Geneeskd; 2007 Jan; 151(3):185-8. PubMed ID: 17288344 [TBL] [Abstract][Full Text] [Related]
6. Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome. Sánchez-Corral P; Melgosa M Br J Haematol; 2010 Sep; 150(5):529-42. PubMed ID: 20629662 [TBL] [Abstract][Full Text] [Related]
7. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Bresin E; Daina E; Noris M; Castelletti F; Stefanov R; Hill P; Goodship TH; Remuzzi G; Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195 [TBL] [Abstract][Full Text] [Related]
20. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. Dragon-Durey MA; Blanc C; Marliot F; Loirat C; Blouin J; Sautes-Fridman C; Fridman WH; Frémeaux-Bacchi V J Med Genet; 2009 Jul; 46(7):447-50. PubMed ID: 19435718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]